Accelrys Insight and
Accelrys Insight for Excel offer research scientists an entirely new way of accessing, visualizing and analyzing data that is locked in disparate locations
across internal discovery teams and networked external partners, helping to lower long-standing barriers to bringing innovative therapeutics to market faster
and more cost effectively.
ACD/ChemAnalytical Workbook is an all-in-one
experiment, workflow and data management tool that allows scientists to document analytical information and benefit from the knowledge gained in future
Cresset announces the release of the Activity Miner module for Torch and Forge. Activity Miner
is a new intuitive SAR interpretation tool that identifies the key 3D structural and electrostatic changes impacting biological activity.
The VANTAGE is for simple to complex lab requirements and
applications. A single vertically integrated system can easily replace four to six other pipetting robots and provides more functionality than other
MultiFlo FX is a fully modular, automat-d reagent dispenser for six- to 1,536-well plates offering BioTek’s unique Parallel Dispense
technology—both peristaltic and syringe pump operation down to 500 nL.
Based on an in-silico model of human ventricular heart cells, Certara’s Cardiac Safety Simulator (CSS) helps sponsors to assess
arrhythmia risk before a new drug candidate enters clinical trials and determine safe drug doses for specific patient populations.
The development of a potency assay for cellular therapy products entails many steps of innovations and discoveries, while keeping in mind the end user and the requirements of the regulatory authorities.
The Camille and Henry Dreyfus Foundation sponsors The
Dreyfus Prize in the Chemical Sciences. The purpose of the foundation is to “to advance the science of chemistry, chemical engineering and related sciences
as a means of improving human relations and circumstances.” This year, the $250,000 Dreyfus prize was, for the first time, focused on chemical
When we went to press with this issue, close to 1 million government workers were furloughed, some members of Congress gave
up their salary pay and government agencies key to the welfare of the drugmaking industry went on a hiatus of undetermined length. The NIH in particular was
already smacked down by the sequestration earlier this year, losing $1.5 billion out of its already stretched-thin operating budget. Now the bruised-up
agency stands to lose an estimated $600 million more when the government reopens.